These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The effectiveness of prenatal serum biomarker screening for neural tube defects in second trimester pregnant women: a meta-analysis. Wang ZP; Li H; Hao LZ; Zhao ZT Prenat Diagn; 2009 Oct; 29(10):960-5. PubMed ID: 19609892 [TBL] [Abstract][Full Text] [Related]
25. Ultrasound and a neural tube screening program in North Carolina. Nelson LH; Anderson SG; Sowers SG; Burton BK N C Med J; 1982 Apr; 43(4):283-6. PubMed ID: 6178044 [No Abstract] [Full Text] [Related]
26. [The use of the screening of maternal serum factors for the prenatal diagnosis of fetal developmental defects and chromosomal diseases]. Arbuzova SB; Nikolenko MI Tsitol Genet; 1995; 29(4):44-7. PubMed ID: 8604526 [TBL] [Abstract][Full Text] [Related]
27. Prenatal screening for neural tube defects. Rajesh R; Thomas SV Natl Med J India; 2001; 14(6):343-6. PubMed ID: 11804365 [TBL] [Abstract][Full Text] [Related]
28. [Maternal serum screening for Down syndrome and neural tube defects]. van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776 [TBL] [Abstract][Full Text] [Related]
33. Open neural tube defects among newborns in Rhode Island. Viner-Brown SI; Cain R; Simon PR Med Health R I; 2001 Apr; 84(4):138-9. PubMed ID: 11347353 [No Abstract] [Full Text] [Related]
34. Maternal serum screening for neural tube defects and fetal chromosome abnormalities. Rose NC; Mennuti MT West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429 [TBL] [Abstract][Full Text] [Related]
35. Maternal serum AFP screening: a programmatic overview. Harisiades JP Issues Health Care Women; 1983; 4(1):17-40. PubMed ID: 6190853 [No Abstract] [Full Text] [Related]
36. Second trimester maternal serum screening for fetal open neural tube defects and aneuploidy. Driscoll DA; Genet Med; 2004; 6(6):540-1. PubMed ID: 15545752 [No Abstract] [Full Text] [Related]
37. [Maternal serum screening for congenital abnormalities and Down syndrome in Sønderjylland County. Eight years of experience]. Christiansen M; Petersen PL; Permin M; Larsen LA; Nørgaard-Pedersen B Ugeskr Laeger; 1999 Dec; 161(50):6928-34. PubMed ID: 10643380 [TBL] [Abstract][Full Text] [Related]
38. [Determination of AFP in serum]. Bachmann C; Kretschmer R; Köchli HP Soz Praventivmed; 1981 Sep; 26(4):225-8. PubMed ID: 6171117 [No Abstract] [Full Text] [Related]
39. Use of patients' data to control alpha-fetoprotein assays when screening for neural tube defects. Hullin DA; Hobbs DR; Woodhead JS Clin Chem; 1988 Sep; 34(9):1928-9. PubMed ID: 2458204 [No Abstract] [Full Text] [Related]
40. Biochemical screening of congenital developmental abnormalities using determination of fetoplacental antigens. Fialová L; Malbohan I; Mikulíková L; Hájek Z Acta Univ Carol Med (Praha); 1993; 39(1-4):3-8. PubMed ID: 9355657 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]